English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 72 Help

Selected(0)Clear Items/Page:    Sort:
Understanding the impact of ChatGPT on tourism and hospitality: Trends, prospects and research agenda Journal article
Sigala, Marianna, Ooi, Keng Boon, Tan, Garry Wei Han, Aw, Eugene Cheng Xi, Buhalis, Dimitrios, Cham, Tat Huei, Chen, Meng Mei, Dwivedi, Yogesh K., Gretzel, Ulrike, Inversini, Alessandro, Jung, Timothy, Law, Rob, Ye, Ivy Huiyue. Understanding the impact of ChatGPT on tourism and hospitality: Trends, prospects and research agenda[J]. Journal of Hospitality and Tourism Management, 2024, 60, 384-390.
Authors:  Sigala, Marianna;  Ooi, Keng Boon;  Tan, Garry Wei Han;  Aw, Eugene Cheng Xi;  Buhalis, Dimitrios; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:7.6/8.3 | Submit date：2024/10/10
Chatgpt  Destination Management  Generative Artificial Intelligence  Hospitality Management  Research Agenda  Sustainable Tourism  Tourism  
“Dual sensitive supramolecular curcumin nanoparticles” in “advanced yeast particles” mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment Journal article
Han, Xiaoqin, Luo, Ruifeng, Qi, Shanshan, Wang, Yanli, Dai, Linxin, Nie, Wenbiao, Lin, Meisi, He, Haoqi, Ye, Naijing, Fu, Chaomei, You, Yu, Fu, Shu, Gao, Fei. “Dual sensitive supramolecular curcumin nanoparticles” in “advanced yeast particles” mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment[J]. Journal of Nanobiotechnology, 2023, 21(1), 321.
Authors:  Han, Xiaoqin;  Luo, Ruifeng;  Qi, Shanshan;  Wang, Yanli;  Dai, Linxin; et al.
Favorite | TC[WOS]:15 TC[Scopus]:16  IF:10.6/11.4 | Submit date：2023/09/22
Curcumin  Macrophage Targeting  Ph/ros Dual-responsive  Supramolecular Nanoparticles  Ulcerative Colitis  Yeast Cell Wall Microparticles  
Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation Journal article
Wu, Ming Yue, Ge, Yun Jun, Wang, Er Jin, Liao, Qi Wen, Ren, Zheng Yu, Yu, Yang, Zhu, Guoyuan, Liu, Chun Ping, Zhang, Meng Ni, Su, Huanxing, Shen, Han Ming, Chen, Ye, Wang, Lei, Wang, Yi Tao, Li, Min, Bian, Zhaoxiang, Chai, Jin, Ye, Richard D., Lu, Jia Hong. Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation[J]. EMBO Molecular Medicine, 2023, 15, e17875.
Authors:  Wu, Ming Yue;  Ge, Yun Jun;  Wang, Er Jin;  Liao, Qi Wen;  Ren, Zheng Yu; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:9.0/11.0 | Submit date：2024/01/02
Columbamine  Fpr2  Inflammatory Bowel Disease  Lc3-associated Efferocytosis  
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 Journal article
Huang, Mu Yang, Chen, Yu Chi, Lyu, Wen Yu, He, Xin Yu, Ye, Zi Han, Huang, Can Yu, He, Xin Ling, Chen, Xiuping, Chen, Xiaobing, Zhang, Baoxian, Kai, Guoyin, Zhang, Xiaolei, Li, Ting, Huang, Mingqing, Lu, Jin Jian. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10[J]. Pharmacological Research, 2023, 198, 106988.
Authors:  Huang, Mu Yang;  Chen, Yu Chi;  Lyu, Wen Yu;  He, Xin Yu;  Ye, Zi Han; et al.
Favorite | TC[WOS]:10 TC[Scopus]:14  IF:9.1/9.0 | Submit date：2024/01/02
Combination Treatment  Ginsenoside Rh2  Pd-1/pd-l1  t Cells  Tumor Microenvironment  
Predicting liposome formulations by the integrated machine learning and molecular modeling approaches Journal article
Han, Run, Ye, Zhuyifan, Zhang, Yunsen, Cheng, Yaxin, Zheng, Ying, Ouyang, Defang. Predicting liposome formulations by the integrated machine learning and molecular modeling approaches[J]. Asian Journal of Pharmaceutical Sciences, 2023, 18(3), 100811.
Authors:  Han, Run;  Ye, Zhuyifan;  Zhang, Yunsen;  Cheng, Yaxin;  Zheng, Ying; et al.
Favorite | TC[WOS]:13 TC[Scopus]:13  IF:10.7/9.0 | Submit date：2023/06/05
Formulation Prediction  Liposome  Machine Learning  Molecular Modeling  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:  Ye,Zi Han;  Yu,Wei Bang;  Huang,Mu Yang;  Chen,Jun;  Lu,Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/08/03
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Review article
2023
Authors:  Ye, Zi Han;  Yu, Wei Bang;  Huang, Mu Yang;  Chen, Jun;  Lu, Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/05/02
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
The impact of isolation kernel on agglomerative hierarchical clustering algorithms Journal article
Han,Xin, Zhu,Ye, Ting,Kai Ming, Li,Gang. The impact of isolation kernel on agglomerative hierarchical clustering algorithms[J]. Pattern Recognition, 2023, 139, 109517.
Authors:  Han,Xin;  Zhu,Ye;  Ting,Kai Ming;  Li,Gang
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:7.5/7.6 | Submit date：2023/08/03
Agglomerative Hierarchical Clustering  Dendrogram Purity  Gaussian Kernel  Isolation Kernel  Varied Densities  
Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease Journal article
Shasha Cheng, Yi Kuang, Guodong Li, Jia Wu, Chung-Nga Ko, Wanhe Wang, Dik-Lung Ma, Min Ye, Chung-Hang Leung. Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease[J]. Pharmaceuticals, 2022, 16(1), 14.
Authors:  Shasha Cheng;  Yi Kuang;  Guodong Li;  Jia Wu;  Chung-Nga Ko; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:4.3/4.6 | Submit date：2023/02/08
Alcoholic Liver Disease (Ald)  Glycogen Synthase Kinase 3β (Gsk3β)  Hepatoprotective  Keap1–nrf2 Protein–protein Interaction (Ppi)  
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer Journal article
Wei-Bang Yu, Yu-Chi Chen,, Can-Yu Huang, Zi-Han Ye, Wei Shi, Hong Zhu, Jia-Jie Shi, Jun Chen, Jin-Jian Lu. CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer[J]. Frontiers of Medicine, 2022, 17(1), 105-118.
Authors:  Wei-Bang Yu;  Yu-Chi Chen,;  Can-Yu Huang;  Zi-Han Ye;  Wei Shi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.9/5.4 | Submit date：2023/01/30
Adcp  Anti-cd47 Antibody  Combination Strategy  Egfr  Osimertinib